{{Multiple issues|
{{one source|date=April 2014}}
{{notability|date=April 2014}}
{{Citations broken|date=April 2014}}
}}

{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 451549928
| IUPAC_name = 7-chloro-5-(2-chlorophenyl)-1-[2-(4-methylphenyl)sulfonylethyl]-3''H''-1,4-benzodiazepin-2-one
| image = Tolufazepam.svg
| width = 180

<!--Clinical data-->
| tradename =  
| legal_status =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 86273-92-9
| PubChem = 65647
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 98SR74X50D
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID      = 59084

<!--Chemical data-->
| C=24 | H=20 | Cl=2 | N=2 | O=3 | S=1 
| molecular_weight = 487.397 g/mol
| smiles = Clc2ccccc2C(=NCC1=O)c3cc(Cl)ccc3N1CCS(=O)(=O)c(cc4)ccc4C
| StdInChI_Ref = {{stdinchicite|changed|chemspider}}
| StdInChI          = 1S/C24H20Cl2N2O3S/c1-16-6-9-18(10-7-16)32(30,31)13-12-28-22-11-8-17(25)14-20(22)24(27-15-23(28)29)19-4-2-3-5-21(19)26/h2-11,14H,12-13,15H2,1H3
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}}
| StdInChIKey       = FFZOBTGTWSRRMB-UHFFFAOYSA-N
}}

'''Tolufazepam''' is a drug that is a [[benzodiazepine]] derivative.<ref>{{Cite journal |author= |title=LIST OF INTERNATIONAL NON-PROPRIETARY NAMES (INNS), PROVIDED FOR PHARMACEUTICAL SUBSTANCES BY THE WORLD HEALTH ORGANIZATION, WHICH ARE FREE OF DUTY |journal=Official Journal of the European Communities |format=PDF |publisher=eur-lex.europa.eu |date=23 October 2001 |accessdate=7 December 2009 |url=http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:279:0767:0876:EN:PDF |archive-url=https://archive.is/20140627223035/http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2001:279:0767:0876:EN:PDF |dead-url=yes |archive-date=27 June 2014 }}</ref> Studies have shown tolufazepam to have anticonvulsant and anxiolytic activity in animal subjects,<ref>{{Cite book|url=https://doi.org/10.1016/S0065-7743(08)60524-2|title=Chapter 2. Antianxiety Agents and Anticonvulsants|last=Hrib|first=Nicholas J.|last2=Martin|first2=Lawrence L.|pages=11–20|doi=10.1016/s0065-7743(08)60524-2}}</ref> including convulsions elicited by [[pentylenetetrazol]].<ref>{{Cite journal|last=Pérez|first=C.|last2=Mondelo|first2=N.|last3=Stéfano|first3=F. J.|last4=Lores Arnaiz|first4=J.|date=May 1988|title=Pharmacological activity of novel alkylsulfonylaryl-1-substituted-1,4-benzodiazepine derivatives|url=https://www.ncbi.nlm.nih.gov/pubmed/2901826|journal=Archives Internationales De Pharmacodynamie Et De Therapie|volume=293|pages=57–68|issn=0003-9780|pmid=2901826}}</ref>

==See also==
*[[Benzodiazepine]]

==References==
{{Reflist}}

{{Benzodiazepines}}
{{GABAAR PAMs}}

[[Category:Benzodiazepines]]
[[Category:Chloroarenes]]
[[Category:GABAA receptor positive allosteric modulators]]
[[Category:Lactams]]
[[Category:Sulfones]]

{{sedative-stub}}